Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Navigo Workstation 2.3 (FPRMC00039)

K-Number: K250664 · 2025-08-07

Decision Date2025-08-07
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Navigo Workstation 2.3 (FPRMC00039) is a medical device manufactured by UC-CARE , Ltd.. It received FDA 510(k) clearance on 2025-08-07 under approval number K250664. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Navigo Workstation 2.3 (FPRMC00039)?

Navigo Workstation 2.3 (FPRMC00039) is a medical device that received FDA 510(k) clearance on 2025-08-07. It is manufactured by UC-CARE , Ltd.. The 510(k) number is K250664.

When was Navigo Workstation 2.3 (FPRMC00039) approved by the FDA?

Navigo Workstation 2.3 (FPRMC00039) received FDA 510(k) clearance on 2025-08-07, under approval number K250664.

What company makes Navigo Workstation 2.3 (FPRMC00039)?

Navigo Workstation 2.3 (FPRMC00039) is manufactured by UC-CARE , Ltd..

What is the FDA product code for Navigo Workstation 2.3 (FPRMC00039)?

The FDA product code for Navigo Workstation 2.3 (FPRMC00039) is LLZ.

Other Devices by UC-CARE , Ltd.

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.